Show simple item record

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

dc.contributor.authorMorschhauser, F.
dc.contributor.authorDyer, M. J. S.
dc.contributor.authorWalter, H. S.
dc.contributor.authorDanilov, A. V.
dc.contributor.authorYsebaert, L.
dc.contributor.authorHodson, D. J.
dc.contributor.authorFegan, C.
dc.contributor.authorRule, S. A.
dc.contributor.authorRadford, John A
dc.contributor.authorCartron, G.
dc.contributor.authorBouabdallah, K.
dc.contributor.authorDavies, A. J.
dc.contributor.authorSpurgeon, S.
dc.contributor.authorRajakumaraswamy, N.
dc.contributor.authorLi, B.
dc.contributor.authorHumeniuk, R.
dc.contributor.authorHuang, X.
dc.contributor.authorBhargava, P.
dc.contributor.authorJürgensmeier, J. M.
dc.contributor.authorSalles, G.
dc.date.accessioned2021-01-25T01:13:47Z
dc.date.available2021-01-25T01:13:47Z
dc.date.issued2020en
dc.identifier.citationMorschhauser F, Dyer MJS, Walter HS, Danilov AV, Ysebaert L, Hodson DJ, et al. Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. Leukemia. 2020.en
dc.identifier.pmid33328591en
dc.identifier.doi10.1038/s41375-020-01108-xen
dc.identifier.urihttp://hdl.handle.net/10541/623729
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1038/s41375-020-01108-xen
dc.titlePhase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphomaen
dc.typeArticleen
dc.contributor.departmentUniv. Lille, CHU Lille, ULR 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.en
dc.identifier.journalLeukemiaen
dc.description.noteen]
refterms.dateFOA2021-01-25T10:41:15Z


Files in this item

Thumbnail
Name:
33328591.pdf
Size:
476.9Kb
Format:
PDF
Description:
From UNPAYWALL
Download

This item appears in the following Collection(s)

Show simple item record